Category Archives: Stem Cell Research

Stem Cell Research News Topix

Posted: July 17, 2016 at 6:40 am

Cell and Stem Cell Conferences | Exhibitions | Worldwide …

Posted: July 17, 2016 at 6:40 am

OMICS International Conferences invites all the participants from all over the world to attend '6th World Congress on Cell & Stem Cell Research during February 29-March 02, 2016 in Philadelphia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions

Track01:Stem Cell

The most well-established and widely used stem cell treatment is thetransplantationof blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. Since the 1970s,skin stem cellshave been used to grow skin grafts for patients with severe burns on very large areas of the body. Only a few clinical centers are able to carry out this treatment and it is usually reserved for patients with life-threatening burns. It is also not a perfect solution: the new skin has no hair follicles or sweat glands. Research aimed at improving the technique is ongoing.

Related Conferences:

International Conference on Pancreatic andColorectal Cancer, March 29-30, 2016, Atlanta, USA; International Conference onProstate Cancerand Treatment, May 5-7, 2016, Chicago, USA;Cancer DiagnosticsConference & Expo, June 13-15, 2016, Rome, Italy; International Conference onTissue Scienceand Regenerative Medicine, Sept 12-14, 2016, Berlin Germany;Gene Regulatory Networks and the Encoded Causality of Development, May 16-18, 2016, California, USA; Stem Cell Models of Neural Degeneration and Disease, February 1-3, 2016 Dresden, Germany;Stem Cellsand Cancer, March 6-10, 2016, Colorado, USA; Transdifferentiation and Tissue Plasticity inCardiovascular Rejuvenation; February 7-10, 2016, West Sussex, UKTrack 01:Cell Differentiation:

Cellular differentiation is the progression, whereas a cell changes from one cell type to another. Variation occurs numerous times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types. Differentiation continues in adulthood as adult stem cells divide and create fully differentiated daughter cells during tissue repair and during normal cell turnover. Some differentiation occurs in response to antigen exposure. Differentiation dramatically changes a cell's size, shape, membrane potential, metabolic activity, and responsiveness to signals. These changes are largely due to highly controlled modifications in gene expression and are the study of epigenetics. With a few exceptions, cellular differentiation almost never involves a change in the DNA sequence itself. Thus, different cells can have very different physical characteristics despite having the same genome.

Related Conferences:

5th International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016,San Antonio, USAInternational Conference on Melanoma and Carcinoma, July 14-15, 2016,Brisbane, Australia,Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil;4th International Conference on Blood Malignancies and Treatment,April 18-20, 2016,Dubai, UAE; 2ndInternational Congress onNeuroimmunology& Therapeutics, March 31-Apr 2, 2016, Atlanta, USA; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016 , Colorado, USA; Phacilitate Cell & Gene Therapy World, January 25-27, Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, 1-3 February 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016 Colorado, USA

Track02:Cell Metabolism:

Metabolism is the set of life-nourishing chemical transformations within the cells of living organisms. These enzyme-catalyzed reactions allow organisms to grow and reproduce, maintain their structures, and respond to their environments. Metabolism is divided into two categories: catabolism, the breaking down of organic matter by way of cellular respiration, and anabolism, the building up of components of cells such as proteins and nucleic acids.

Related Conferences:

International Conference on Tissue Science and Regenerative Medicine, Sept 12-14, 2016, Berlin Germany; International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Atlanta, USA; International Conference on Prostate Cancer and Treatment, May 5-7, 2016, Chicago, USA; Cancer Diagnostics Conference & Expo, June 13-15, 2016, Rome, Italy; International Conference Bimolecular Engineering, January 5-7, 2016, Singapore; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016, Colorado, USA; Metabolism, Transcription and Disease, January 10-14, 2016, Iquitos, Peru; Gordon Research Conference & Seminar "Origins of Life", January 17-22, 2016, Galveston, USA; Small RNA Silencing Little Guides, Big Biology, January 24-28, 2016, Colorado, USA

Track03:Tissue Engineering:

Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. Powerful developments in the multidisciplinary field of tissue engineering have produced a novel set of tissue replacement parts and implementation approaches. Scientific advances in biomaterials, stem cells, growth and differentiation factors, and biomimetic environments have created unique opportunities to fabricate tissues in the laboratory from combinations of engineered extracellular matrices cells, and biologically active molecules.

Related Conferences:

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, USA; Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; International Conference on Tissue Engineering and Regenerative Medicine, June 9-10, 2016, San Francisco, USA; Keystone Stem Cells and Regeneration in the Digestive Organs, March 13-17, 2016 Colorado, USA; ISSCR Pluripotency: From basic science to therapeutic applications, 22-24, March 2016 Kyoto, Japan; Keystone Cardiac Development, Regeneration and Repair, April 3-7, 2016 Utah, USA; The Stem Cell NicheDevelopment & Disease, 22-26, May 2016, Hillerd, Denmark

Track04:Epigenetics:

Epigenetics is the study of genetics, cellular and physiological phenotypic trait variations that are caused by external or environmental factors that switch genes on and off and affect how cells read genes instead of being caused by changes in the DNA sequence. Epigenetic change in eukaryotic biology is the process of cellular differentiation. During morphogenesis, totipotent stem cells become the various pluripotent cell lines of the embryo, which in turn become fully differentiated cells.

Related Conferences:

International Conference on Cancer Genomics, Aug 8-9, 2016, Las Vegas, USA; International Conference on Genetics Counseling and Genomics Medicine, Aug 11-12, 2016, Birmingham, UK; Biotechnology World Convention, Aug 15-17, 2016, Sao Paulo, Brazil; International Conference on Synthetic Biology, Aug 18-19, 2016, London, UK, Annual Conference on Bio Science, Sept 12-13, 2016, Berlin, Germany; Noncoding RNAs in Health and Disease, February 21-24, 2016, Santa Fe, USA; Maintenance of Genome Stability March 7- 10, 2016, Panama, South America; Chromatin and Epigenetics, March 20-24, 2016 Whistler, Canada; Chromatin, Non-Coding RNAs and RNAP II Regulation in Development and Disease, March 29, 2016, Austin, USA; Chromatin Structure & Function, May 22-27, 2016, Les Diablerets, Switzerland

Track05:Gene Therapy:

Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. The polymers are either expressed as proteins, interfere with protein expression, or possibly correct genetic mutations. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Related Conferences:

5thWorld Congress on Hemophilia, June 6-8, 2016, London, UK; 2nd World Bio Summit & Expo, Oct 13-15, 2016, Dubai, UAE; 4th International Conference on Genomics & Pharmacogenomics, Sept 12-14, 2016, Berlin Germany; International Conference on Molecular Biology, Oct 13-15, 2016, Dubai, UAE; World Congress on Human Genetics, Oct 31 - Nov 2, 2016, Valencia, Spain; International Conference on Cell and Gene Therapy, March 3-4, 2016, Singapore; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016, Colorado, USA; Axons: from cell biology to pathology, January 24-27, 2016, New Mexico; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA

Track07:Cell Biology of Aging:

Aging process is the result of the inability of various types of stem cells to continue to replenish the tissues of an organism with functional differentiated cells capable of maintaining that tissues (or organ's) original function.

Related Conferences:

International Conference on Cancer Genomics, Aug 8-9, 2016, Las Vegas, USA; International Conference on Genetics Counseling and Genomics Medicine, Aug 11-12, 2016, Birmingham, UK; Biotechnology World Convention, Aug 15-17, 2016, Sao Paulo, Brazil;International Conference on Medical Ethics and Health Policies, June 9-11, 2016, London, UK, Annual Conference on Bio Science, Sept 12-13, 2016, Berlin, Germany; International Aging and Disease Conference, October 01-02, 2016, Stanford, USA; 4th World Parkinson Congress, September 5-6, 2016 Portland, USA; Disasters in an Ageing World-Readiness, Resilience and Recovery, June 21-23, 2016, Brisbane, Australia; American Geriatrics Society Annual Scientific Meeting, May 19-21, 2016, Long Beach, USA; American Society on Aging (ASA) 2016 Aging in America Conference, March 20-24, 2016, Washington, USA

Track08:Computational Biology:

Computational Biology, sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency. In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies.

Related Conferences:

6thInternational Conference on Bioinformatics, March 29-30, 2016 Valencia, Spain;6th International Conference and Expo on Proteomics, March 29-31, 2016, Atlanta, USA; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; International Conference on Computational Biology, Paris, France; February 22-23, 2016 Systems Immunology: From Molecular Networks to Human Biology, January 10-14, 2016 Montana, United States; Whole-Cell Modeling Summer School, April 3-8, 2016 Barcelona, Spain; From Functional Genomics to Systems Biology, November 12-15, 2016, Heidelberg, Germany

Track09:Genetic Engineering:

Genetic engineering is the direct manipulation of an organism's genome using biotechnology. Whereas set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA may be inserted in the host genome by first isolating and copying the genetic material of interest using molecular cloning methods to generate a DNA sequence, or by synthesizing the DNA, and then inserting this construct into the host organism.

Embryonic stem cells have a major potential for studying early steps of development and for use in cell therapy. In many situations, however, it will be necessary to genetically engineer these cells. A novel generation of lentivectors which permit easy genetic engineering of mouse and human embryonic stem cells.

Related Conferences:

Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; 5thInternational Conference and Exhibition on Cell andGene Therapy, May 19-21, 2016 San Antonio, USA; International Conference Biomolecular Engineering, Singapore; Cell Culture 2016, London, UK; 4thBiotechnology World Congress, Dubai, UAE; Genome Editing and Gene Modulation Congress 2016, Oxford, UK; European Symposium on Biochemical Engineering Sciences 2016, Dublin, Ireland

Track10:Apoptosis:

Apoptosis is the process of programmed cell death (PCD) that may occur in multicellular organisms. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, chromosomal DNA fragmentation, and global mRNA decay. Most cytotoxic anticancer agents induce apoptosis, raising the intriguing possibility that defects in apoptotic programs contribute to treatment failure. Because the same mutations that suppress apoptosis during tumor development also reduce treatment sensitivity, apoptosis provides a conceptual framework to link cancer genetics with cancer therapy.

Related Conferences:

14th World Congress on Cancer Therapy, Dec 8-10, 2016, Dallas, USA; 13th Global Oncologists Summit and Cancer Therapy, Oct 17-19, 2016, Dubai, UAE; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, London, UK; International Conference on Cervical Cancer, Sept 22-23, 2016, Vienna, Austria; 2nd World Congress on Breast Cancer, Sept 19-21, 2016, Pheonix, USA; Cell Death, July 3-8, 2016 Girona, Spain; A Matter of Life or Death: Cell Death in Cancer, January 28 -30, 2016 Amsterdam, Netherlands; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6-10, 2016 Whistler, Canada; Symposium on Signalling Pathways in Cancer 2016: Focusing on the HER/EGFR family signalling, March 04-05, 2016, Barcelona, Spain

Track11:Somatic Cell Therapy:

Somatic cell therapy is the administration to humans of autologous, allogeneic, or xenogeneic living cells which have been manipulated or processed ex vivo. Manufacture of products for somatic cell therapy involves the ex vivo propagation, expansion, selection. Somatic cell therapy is viewed as a more conservative, safer approach because it affects only the targeted cells in the patient, and is not passed on to future generations. Somatic gene therapy represents mainstream basic and clinical research, in which therapeutic DNA (either integrated in the genome or as an external episome or plasmid) is used to treat disease. Most focus on severe genetic disorders, including immunodeficiencies, haemophilia, thalassaemia and cystic fibrosis. Such single gene disorders are good candidates for somatic cell therapy.

Related Conferences:

2nd International Conference on Antimicrobial Agents and Chemotherapy, June 6-7, 2016 Dallas, USA;9th Global Diabetelogists Annual Meeting and Medicare Expo, June 6-8, 2016, Dallas, USA; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; International Conference Biomolecular Engineering, Singapore; Cell Culture 2016, London, UK; Reprogramming Cell Fate, March 04-05, 2016, Texas, USA; International Conference on Cell and Gene Therapy, July 25-26, 2016 Paris, France; Derivation and Culture of Human Induced Pluripotent Stem Cells, Hinxton, UK; Axons: from cell biology to pathology, New Mexico; Annual Meeting of the Japan Society of Gene Therapy (JSGT), October 18 -21, 2016, Japan

Track12:Histology of Cell biology:

Histology is the scientific study of biological tissues. It is the microscopic study of the structure of biological tissues using special staining techniques combined with light and electron microscopy. Histology is the study of the microscopic structures of cells and tissues of plants and animals. Histological studies may be conducted using tissue culture, where live human or animal cells are isolated and maintained in an artificial environment for various research projects. The ability to visualize microscopic structures is frequently enhanced through the use of histological stains. Histology is an essential tool of biology and medicine.

Related Conferences:

Annual Plant Genomics Conference, July 14-15, 2016, Brisbane, Australia; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; Asia Pacific Biotech Congress, July 25-27, 2016, Bangkok, Thailand; 5thInternational Conference and Exhibition on Cell andGene Therapy, May 19-21, 2016 San Antonio, USA; International Conference Biomolecular Engineering, Singapore; Cell Culture 2016, London, UK; United States & Canadian Academy of Pathology Annual Meeting, March 12-18, 2016, Seattle, USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, February 1-3, 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016, Colorado, USA

Track13:Human Embryology:

Human embryogenesis is the process of cell division and cellular differentiation of the embryo that occurs during the early stages of development. Whereas human development entails growth from a stage celled zygote to an adult human being stage. Fertilization occurs when the sperm cell successfully enters and fuses with an egg cell (ovum). The genetic material of the sperm and egg then combine to form a single cell called a zygote and the germinal stage of prenatal development commences.

Related Conferences:

Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; International Conference on Human Reproduction and Embryology, May 23-24, 2016, London, UK; Conference on Embryology and Developmental Biology, June 1-3, 2016, Nanjing, China; European Society of Human Reproduction and Embryology, July 3-6, 2016, Helsinki, Finland

Track14:Tumour Cell Science:

An abnormal mass of tissue. Tumors are a classic sign of inflammation, and can be benign or malignant. Tomour usually reflect the kind of tissue they arise in. Treatment is also specific to the location and type of the tumor. Benign tumors can sometimes simply be ignored, cancerous tumors; options include chemotherapy, radiation, and surgery.

Related Conferences:

International Conference onCancer Genomics, Aug 8-9, 2016, Las Vegas, USA; International Conference on Genetics Counseling andGenomics Medicine, Aug 11-12, 2016, Birmingham, UK; Biotechnology World Convention, Aug 15-17, 2016, Sao Paulo, Brazil; International Conference onSynthetic Biology, Aug 18-19, 2016, London, UK, Annual Conference onBio Science, Sept 12-13, 2016, Berlin, Germany; Pediatric Oncology Conference, January 20-21, 2016, Brussels, Belgium; Progress and Controversies in Gynecologic Oncology Conference, January 22-23, 2016, Barcelona, Spain; Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies, January 24-28, 2016, British Columbia, Canada; The Cancer Genome, February 7-11, 2016 Banff, Canada

Track15:Stem Cell Biomarkers:

Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery. A number of biomarkers, such as certain cell surface antigens, are used to assign pluripotent ESCs; however, accumulating evidence suggests that ESCs are heterogeneous in morphology, phenotype and function, thereby classified into subpopulations characterized by multiple sets of molecular biomarkers.

Related Conferences:

International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; Stem Cell Research & Regenerative Medicine Conference, April 25-26, 2016, Boston, USA; International Conference on Cell and Stem Cell Engineering, September 15 - 16, 2016, Rome, Italy; International Conference on Stem Cells & Regenerative Medicine, December 17-18, 2016, Bangkok, Thailand; Molecular and Cellular Basis of Growth and Regeneration Breckenridge, January 10-14, 2016, Colorado, USA; Tissue Niches & Resident Stem Cells in Adult Epithelia, August 7-12, Hong Kong, China

Track16:Stem Cell Therapy:

Autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures. Adult stem cells are frequently used in medical therapies, for example in bone marrow transplantation. Human embryonic stem cells may be grown in vivo and stimulated to produce pancreatic -cells and later transplanted to the patient. Its success depends on response of the patients immune system and ability of the transplanted cells to proliferate, differentiate and integrate with the target tissue.

Related Conferences:

9thInternational Conference on Molecular & CellularCardiology, Aug 22-24, 2016, Sao Paulo, Brazil;International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany;2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; Phacilitate Cell & Gene Therapy World, January 25-27, 2016, Washington D.C, USA; International Conference on Nucleic Acids, January 7-8, 2016, Singapore; 5th Zing Nucleic Acids Conference, December 2-5, 2016 Tampa, Florida; Germline Stem Cells Conference, , June 19-21, 2016, San Francisco, USA; Notch Signaling in Development, Regeneration & Disease Gordon Research Conference, July 31-August 5, 2016, Lewiston, USA

Track17:Novel Stem Cell Technologies:

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation. Although early research has focused on haematopoietic stem cells, stem cells have also been recognised in other sites. Research into solid tissue stem cells has not made the same progress as that on haematopoietic stem cells.

Related Conferences:

Cancer Diagnostics Conference & Expo, June 13-15, 2016, Rome, Italy; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; Molecular and Cellular Basis of Growth and Regeneration Breckenridge, January 10-14, 2016, Colorado, USA; Derivation and Culture of Human Induced Pluripotent Stem Cells, Hinxton, UK; Challenges, Solutions and Progress in Stem Cell Medicine, 18-21 February, 2017 San Diego, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016, Heidelberg, Germany

Track 18:Cancer Biology:

Cancer can be defined as a disease in which a group of abnormal cells grow uncontrollably by disregarding the normal rules of cell division. Normal cells are constantly subject to signals that dictate whether the cells should divide, differentiate into another cell or die. Cancer cells develop a degree of anatomy from these signals, resulting in uncontrolled growth and proliferation. If this proliferation is allowed to continue and spread, it can be fatal.

Related Conferences:

14th World Congress on Cancer Therapy, Dec 8-10, 2016, Dallas, USA; 13th Global Oncologists Summit and Cancer Therapy, Oct 17-19, 2016, Dubai, UAE; 12th Euro Global Summit on Cancer Therapy, Sept 26-28, 2016, London, UK; International Conference on Cervical Cancer, Sept 22-23, 2016, Vienna, Austria; 2nd World Congress on Breast Cancer, Sept 19-21, 2016, Pheonix, USA; ESMO Sarcoma & GIST Conference 2016, 16-17 February, 2016 Milan, Italy; ESMO Symposium on Signalling Pathways in Cancer 2016: Focusing on the HER/EGFR family signalling, March 4-5, 2016, Barcelona, Spain; European Lung Cancer Conference, April 13-16, 2016, Geneva, IMPAKT 2016 Breast Cancer Conference, May 12-14, 2016, Brussels, Belgium; World Congress on Gastrointestinal Cancer 2016, 29-02 July, 2016, Barcelona, Spain

Stem Cell Research is an international forum to present and discuss current perspectives in cell and stem cell research. Stem Cell Research is the unified study of the properties of cells and living organisms and all aspects of their interactions. Stem Cell Research has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.

Related Conferences:

5th International Conference and Exhibition on Cell & Gene Therapy, May 19-21, 2016, San Antonio, USA; Annual Conference Stem Cell and Regenerative on Medicine, Aug 4-6, 2016, Frankfurt, Germany; 9th International Conference on Molecular & Cellular Cardiology, Aug 22-24, 2016, Sao Paulo, Brazil; 2nd International Conference and Exhibition on Tissue preservation and Bio-banking, Aug 18-19, 2016, Portland, Oregon; Molecular and Cellular Basis of Growth and Regeneration, January 10-14, 2016 , Colorado, USA; Phacilitate Cell & Gene Therapy World, January 25-27, Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease, 1-3 February 2016, Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration, March 13-18, 2016, California, USA; Keystone Stem Cells and Cancer, March 6-10, 2016 Colorado, USA

6th World Congress on Cell & Stem Cell Research

The success of the 5thCell Science conference series has given us the prospect to bring the gathering one more time for our 6thWorld Congress 2016 meet in Philadelphia, USA. Since its commencement in 2011 cell science series has perceived around 500 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time.

Stem Cell Research-2016has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need.World Congress 2016 will have an anticipated participation of 150-200 delegates from around the world to discuss the conference goal.

History of Stem cells Research

Stem cells have an interesting history, in the mid-1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood 1981: First in vitro stem cell line developed from mice 1988: Embryonic stem cell lines created from a hamster 1995: First embryonic stem cell line derived from a primate 1997: Cloned lamb from stem cells 1997: Leukaemia origin found as haematopoietic stem cell, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cell research in the United States, but only placed restrictions on funding and use, under Congress's power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of humanembryonic stem cells. Prior to President Obama's executive order, federal funding was limited to non-embryonic stem cell research and embryonic stem cell research based uponembryonic stem celllines in existence prior to August 9, 2001. In 2011, a United States District Court "threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research.

Members Associated with Stem Cell Research:

Discussion on Development, Regeneration, and Stem Cell Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cell Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and evo-devo (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Cell Therapy Market, By Region, 2009 2018

$Million

Figure 1:Market by Geography

Why to attend???

Stem Cell Research-2016 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://stemcell.omicsgroup.com/sponsors.php

UAS Major Universities which deals with Stem Cell Research

University of Washington/Hutchinson Cancer Center

Original post:
Cell and Stem Cell Conferences | Exhibitions | Worldwide ...

Posted in Stem Cell Research | Comments Off

Texans for Stem Cell Research

Posted: July 17, 2016 at 6:40 am

This is the amount we raised due all of you!

Thank you to all of our sponsors, musicians golfers, cooks, volunteers, and everyone else that helped make our "Swingin' n' Singin' for Cures" an incredible event.

We have a goal of raising another $78,000 by October 31st, 2014.

So please help spread the word and tell your friends to please hit the Donate button here on our home page and let's get to this goal!

These funds will go directly to the groundbreaking research of Dr. Will Decker and Ratan Bhardwaj, two members of our Medical Advisory Committee. Please read their executive summary link on this page to learn how their t-cell immunology to treat tumors may make chemo and radiation treatments a thing of the past!

Also TSCR will be represented at this year's World Stem Cell Summit in San Antonio, December 3-5th. TSCR's Chairman, David L. Bales has been asked to speak on grass roots stem cell advocacy.

We are honored to be able to speak on behalf of all Texans that support stem cell research and regenerative medicine.

The rest is here:
Texans for Stem Cell Research

Posted in Stem Cell Research | Comments Off

Does Texas Have Research Now? | Texans for Stem Cell Research

Posted: July 17, 2016 at 6:40 am

The following locations are currently performing research or trials in Texas.

Texas A&M University Mesenchymal Stem Cell Distribution Prepares and distributes well-characterized marrow stromal cells (MSCs) derived from adult human and rodent bone marrow using standardized protocols.

Texas Heart Institute Stem Cell Center Dedicated to the study of adult stem cells and their role in treating cardiovascular disease, including clinical trials (in human patients), as well as many preclinical studies (in the laboratory) using stem cells.

ClinicalTrial.gov A registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.

ClinicalTrials at MDAndersonCancer Center The Houston, Texas based Cancer Center is involved in many exiciting trials.

Institute for RegenerativeMedicine The goal of the IRM is to bridge the gap between basic science and clinical translation in the field of regenerative medicine and experimental cell therapeutics. Through active collaboration between basic scientists and clinicians in Central Texas, the IRM hopes to tackle the ambitious task of discovering novel therapies for intractable diseases to relieve human suffering.

Posted in Stem Cell Research | Comments Off

Embryonic stem cell research: an ethical dilemma | Europe’s …

Posted: July 17, 2016 at 6:40 am

A human embryo can split into twins or triplets until about 14 days after fertilization

Egg and sperm: some people believe an embryo must be fully protected from conception onwards (Wellcome Images/Spike Walker)

Human blastocyst on the tip of a pin: embryonic stem cells can be grown from cells found in the blastocyst (Wellcome Images/Yorgos Nikas)

Some people think an embryo deserves special protection from about 14 days after fertilization

Many patients could one day benefit from embryonic stem cell research

The rules controlling embryonic stem cell research vary around the world and have been the topic of much discussion

Embryonic stem cell research poses a moral dilemma. It forces us to choose between two moral principles:

In the case of embryonic stem cell research, it is impossible to respect both moral principles.To obtain embryonic stem cells, the early embryo has to be destroyed. This means destroying a potential human life. But embryonic stem cell research could lead to the discovery of new medical treatments that would alleviate the suffering of many people. So which moral principle should have the upper hand in this situation? The answer hinges on how we view the embryo. Does it have the status of a person?

Chapter 1 of this film introduces some of the key ethical arguments. Watch this film and others on our films page.

The moral status of the embryo is a controversial and complex issue. The main viewpoints are outlined below.

1. The embryo has full moral status from fertilization onwards Either the embryo is viewed as a person whilst it is still an embryo, or it is seen as a potential person. The criteria for personhood are notoriously unclear; different people define what makes a person in different ways.

Development from a fertilized egg into to baby is a continuous process and any attempt to pinpoint when personhood begins is arbitrary. A human embryo is a human being in the embryonic stage, just as an infant is a human being in the infant stage. Although an embryo does not currently have the characteristics of a person, it will become a person and should be given the respect and dignity of a person.

An early embryo that has not yet implanted into the uterus does not have the psychological, emotional or physical properties that we associate with being a person. It therefore does not have any interests to be protected and we can use it for the benefit of patients (who ARE persons).

The embryo cannot develop into a child without being transferred to a womans uterus. It needs external help to develop. Even then, the probability that embryos used for in vitro fertilization will develop into full-term successful births is low. Something that could potentially become a person should not be treated as if it actually were a person

2. There is a cut-off point at 14 days after fertilization Some people argue that a human embryo deserves special protection from around day 14 after fertilization because:

3. The embryo has increasing status as it develops An embryo deserves some protection from the moment the sperm fertilizes the egg, and its moral status increases as it becomes more human-like.

There are several stages of development that could be given increasing moral status:

1. Implantation of the embryo into the uterus wall around six days after fertilization. 2. Appearance of the primitive streak the beginnings of the nervous system at around 14 days. 3. The phase when the baby could survive if born prematurely. 4. Birth.

If a life is lost, we tend to feel differently about it depending on the stage of the lost life. A fertilized egg before implantation in the uterus could be granted a lesser degree of respect than a human fetus or a born baby.

More than half of all fertilized eggs are lost due to natural causes. If the natural process involves such loss, then using some embryos in stem cell research should not worry us either.

We protect a persons life and interests not because they are valuable from the point of view of the universe, but because they are important to the person concerned. Whatever moral status the human embryo has for us, the life that it lives has a value to the embryo itself.

If we judge the moral status of the embryo from its age, then we are making arbitrary decisions about who is human. For example, even if we say formation of the nervous system marks the start of personhood, we still would not say a patient who has lost nerve cells in a stroke has become less human.

If we are not sure whether a fertilized egg should be considered a human being, then we should not destroy it. A hunter does not shoot if he is not sure whether his target is a deer or a man.

4. The embryo has no moral status at all An embryo is organic material with a status no different from other body parts.

Fertilized human eggs are just parts of other peoples bodies until they have developed enough to survive independently. The only respect due to blastocysts is the respect that should be shown to other peoples property. If we destroy a blastocyst before implantation into the uterus we do not harm it because it has no beliefs, desires, expectations, aims or purposes to be harmed.

By taking embryonic stem cells out of an early embryo, we prevent the embryo from developing in its normal way. This means it is prevented from becoming what it was programmed to become a human being.

Different religions view the status of the early human embryo in different ways. For example, the Roman Catholic, Orthodox and conservative Protestant Churches believe the embryo has the status of a human from conception and no embryo research should be permitted. Judaism and Islam emphasize the importance of helping others and argue that the embryo does not have full human status before 40 days, so both these religions permit some research on embryos. Other religions take other positions. You can read more about this by downloading the extended version of this factsheet below.

Extended factsheet with a fuller discussion of the issues by Kristina Hug (pdf) EuroStemCell film "Conversations: ethics, science, stem cells" EuroStemCell factsheet on ethical issues relating to the sources of embyronic stem cells EuroStemCell factsheet on the science of embryonic stem cells EuroStemCell FAQ on human embryonic stem cells and their use in research EuroStemCell summaries of regulations on stem cell research in Europe Booklet for 16+ year olds about stem cells and ethics from the BBSRC Research paper on the ethics of embryonic stem cell research by Kristina Hug

This factsheet was created by Kristina Hug and reviewed by Gran Hermern.

Images courtesy of Wellcome Images: Egg and sperm by Spike Walker; Blastocyst on pin by Yorgos Nikas; Diabetes patient injecting insulin by the Wellcome library, London.

Other images from "Conversations : ethics, science, stem cells", a film by EuroStemCell.

Posted in Stem Cell Research | Comments Off

Stem Cell 100 Longevity Telomere Support Supplement SC100 …

Posted: July 17, 2016 at 6:40 am

Stem Cell 100 is designed to rejuvenate your body and slow the aging process to help you feel and function more like a young person. This can help you feel better, look younger and improve your health.

Most of the cells in your body lose function with age. Everyone has special cells called adult stem cells which are needed to repair damaged and old tissues, but adult stem cells themselves are also aging.

Until now there was not much you could do about it. Stem Cell 100 rejuvenates adult stem cells and their micro-environments with the proprietary SC100 formula. Stem Cell 100+ is a more powerful and faster acting version of the same nutraceutical.

Developed by experts in the anti-aging field, patent-pending Stem Cell 100 is the only supplement proven to double maximum lifespan of an animal model. No other product or therapy including caloric restriction even comes close.

Harness the Power of Your Own Stem Cells

Millions of people suffer from chronic conditions of aging and disease. Based on international scientific studies in many academic and industry laboratories, there is new hope that many of the conditions afflicting mankind can some day be cured or greatly improved using stem cell regenerative medicine.

Stem Cell 100 offers a way to receive some of the benefits of stem cell therapy today by improving the effectiveness of your own adult stem cells.

Stem Cell 100 Helps to Support:

The statements above have not been reviewed by the FDA. Stem Cell 100 is not a preventive or treatment for any disease.

Help Rejuvenate Your Body by Boosting Your Own Stem Cells

As a child, we are protected from the ravages of aging and can rapidly recover from injury or illness because of the ability of the young regenerative stem cells of children have a superior ability to repair and regenerate most damaged tissues.

As we age, our stem cell populations become depleted and/or slowly lose their capacity to repair. Moreover, the micro-environment (i.e. niches) around stem cells becomes less nurturing with age, so cell turnover and repair are further reduced. This natural progression occurs so slowly that we are barely aware of it, but we start to notice the body changes in our 20s, 30s, 40s, and especially after 50 years of age.

Stem Cell 100 helps adults regain their youthful regenerative potential by stabilizing stem cell function.

Stem Cell 100 works differently than other stem cell products on the market

You may have seen a number of products that are advertised as stimulating or enhancing the number of stem cells. Each person only has a limited number of stem cells so using them up faster may not be a good strategy. Stem Cell 100 is about improving the effectiveness and longevity of your stem cells as well as preserving the stem cell micro-environment. That should be the goal of any effective stem cell therapy and is what Stem Cell 100 is designed to do and what other stem cell products cannot do.

Stem Cell 100 Extends Drosophila (Fruit Fly) Lifespan

In extensive laboratory testing Stem Cell 100 greatly extended both the average and maximum lifespan of Drosophila fruit flies. The study (see Charts below) included three cages of Drosophila fruit flies that were treated with Stem Cell 100 (Cages T1 to T3) and three cages which were untreated controls (Cages C1 to C3). Each cage started with 500 fruit flies including 250 males and 250 females.

The experiment showed that median lifespan more than doubled with a 123% increase.

While fruit flies are not people they are more like us than you might think. Drosophila have a heart and circulatory system, and the most common cause of death is heart failure. Like humans and other mammals (e.g. mice), it is difficult to increase their lifespan significantly.

These observed results outperform every lifespan enhancing treatment ever tested including experiments using genetic modification and dietary restriction.

The longest living fruit fly receiving Stem Cell 100 lived 89 days compared to the longest living untreated control which lived 48 days. It is possible that the single longest living fruit fly lived longer for other reasons such as genetic mutation, however, there were many others that lived almost as long so it was not just an aberation.

The oldest 5% of the treated fruit flies lived 77% longer than the oldest 5% of the control group. It is also important that the study showed an improved ability of the fruit flies to survive stress and illness at all ages not just during old age. Even after the first few days of the study there were already more of the

Stem Cell 100 treated fruit flies alive that survived youth than the control group of untreated fruit flies. For additional information about the study please go to our Longevity page.

SK, Santa Fe, New Mexico

I have been using Stem Cell 100 for about one year. Initially I noticed a boost in energy level, which now remains steady-hence not noticed I have experienced no adverse effects from taking this product. I heartily recommend Stem Cell 100 and plan to continue on it.*

Leslie

Stem Cell 100 has made a noticeable difference in me, including turning my gray hair back to its original color, which supposedly is impossible. The reversal of the gray hair to original color began a couple of months after starting the pill. After about 10 months, the gray hair is mostly gone. At the current rate of improvement, I expect my hair to completely be back to its original color within 1 to 2 months. I think my beard will take longer, but it was the first to gray.

Also, my skin became smoother and younger looking. The skin and hair rely heavily on stem cells, and they seem to benefit strongly from this product. Im so excited about telling people my results because there is nothing that can reverse the graying of hair. It will give me evidence that this supplement thing is really powerful.

Unfortunately, I dont have before and after pictures because I didnt read any claims that the product would affect hair color. I would just say that Im a person who totally believes that it does me no good to imagine things or interpret tings in a way favorable to what I want to believe. When Im convinced enough to make a statement, you can count on it.*

Joey, California

I am a 48 year old working woman. A friend of mine introduced me to Stem Cell 100. After taking Stem Cell 100 for about 4 months my anxiety level has really been diminished. Its a great supplement and I would recommend it to everyone!*

Paul, California

I am an active 61 year old man in excellent health, but had experienced a serious drop in my energy level at the time I enrolled in a 4-month trial of Stem Cell 100. Within a month, my energy increased noticeably and I began to take to my physical activities (running, cycling) with a renewed enthusiasm and intensity level. My mood began to elevate steadily, and soon I had even lost those few stubborn pounds that had eluded me for years. I am very enthusiastic about Stem Cell 100. I look forward to continuing with the new, improved formulation, and would not hesitate to recommend it.*

Mike, Texas

After taking the Stem Cell 100 for the last month my sinuses have also cleared, unplugging my ears for the first time since mid September.*

Tom, Australia

Only after about 2-3 weeks of taking Stem Cell 100 my eye sight returned back to a level where I did not need glasses to work on my computer monitors. My eyes had always been good but had started to deteriorate about a year ago where 50% of the time I had to wear my glasses. I was shocked to find the improvement so quick. I found I was less stressed. No other changes to lifestyle yet a measureable difference.

My fingers would sometimes get stiff in the mornings after long days on the keyboard. This stiffness disappeared. Some of my hair is getting darker. I have a full body of hair that had virtually all turned grey but I noticed that some of my hair was starting regrow brown my original colour. I had some age spots in my left leg that are disappearing. Generally, I feel great.*

Willie, California

As I was sprinting this morning around 6:00am I noticed that I was not hurting anymore! I have been having sore knees, ankles, hamstrings and back for the last couple of years. I usually just ran through it, but I noticed since I have been taking the Stem Cell 100 capsules for about 45 days now, those nagging pains are gone away!*

*DIsclaimer: The testimonials reflect the real life experiences written and voluntarily submitted to us by individuals who used our products. Individual results may vary. We do not claim that any individual experience recounted is typical or representative of what any other consumer might experience.

View More Testimonials

Supplement Facts

Stem Cell 100 and Stem Cell 100+ are Patent-Pending Life Code Nutraceuticals.

All Life Code products arenutraceutical grade and provide the best of science along with the balance of nature. Stem Cell 100+ is vegetarian.

Serving Size: One type O capsule

Servings Per Container: 60 Capsules

Recommended Use: Typical usage of Stem Cell 100 or Stem Cell 100+ is two capsules per day, preferably at meal times. While both capsules can be taken at the same time, it is preferable to separate the two capsules by at least 4 hours. Since Stem Cell 100 is a potent formulation, do not take more than three capsules per day. One capsule per day may be sufficient for those below 110 pounds.

Recommended Users: Anyone from ages 22 and up could benefit from Stem Cell 100 or Stem Cell 100+. Those in their 20s and 30s will like the boost in endurance during sports or exercise, while older users will notice better energy and general health with the potential for some weight loss.

Stem Cell 100 was our first multi-pathway longevity nutraceutical. Stem Cell 100+ is a more advanced, faster acting and powerful version of Stem Cell 100.

Click label to enlarge

Active Stem Cell 100 Ingredients: There are ten herbal components that make up the patent-pending combination in Stem Cell 100. The herbal components are highly extracted natural herbs that are standardized for active components that promote adult stem cells and lower inflammation:

1) Polysaccharides, flavonoids, and astragalosides extracted from Astragalus membranaceus, which has many positive effects on stem cells and the cardiovascular and immune systems.

2) Proprietary natural blueberry flavonoids and other compounds from a stabilized pharmaceutical grade medicinal Vaccinium extract. Activate metabolic PPARS and helps produce healthy levels of cholesterol and inflammation. Also has anti-fungal and anti-viral activity.

3) Flavonoids and oligo-proanthocyanidins (OPCs) extracted from Pine Bark, which greatly reduce oxidative stress, DNA damage, and inflammation.

4) L-Theanine, which is a natural amino acid from Camellia sinesis that reduces mental stress and inflammation while improving cognition and protecting brain cells from ischemic or toxic injury.

5) Pterocarpus Marsupium, which contains two stable resveratrol analogs which promote stem cells, lower inflammation, and stabilized metabolism.

6) Polygonum Multiflorium stem stem is a popular Chinese herbal tonic that fights premature aging and promotes youthfulness. Polygonum is reported to enhance fertility by improving sperm count in men and egg vitality in women. Polygonum is also widely used in Asia to strengthen muscle and is thus used by many athletes as an essential tonic for providing strength and stamina to the body.

Modern research has supported Polygonum multiflorium stem in that animal studies have proven that it can extend lifespan and improve the quality of life. Polygonum appears to protect the liver and brain against damage, perhaps by improving immune and cardiovascular health. The stem sections of Polygonum multiflorium are also calming to the nervous system and promote sounder sleep. Life Code uses a proprietary Polygonum multiflorium stem extract.

7) Schisandra Berry is used by many Chinese women to preserve their youthful beauty. For thousands of years, Schisandra has been prized as an antiaging tonic that increases stamina and mental clarity, while fighting stress and fatigue. In Chinese traditional medicine, Schisandra berry has been used for liver disorders and to enhance resistance to infection and promote skin health and better sleep.

Schisandra berry is classified as an adaptogen, which can stimulate the central nervous system, increase brain efficiency, improve reflexes, and enhance endurance. Modern research indicates that Schisandra berry extracts have a protective effect on the liver and promote immunity. A double-blind human trial suggested that Schisandra berry may help patients with viral hepatitis, which is very prevalent in China.

Recent work indicates that the liver is protected by the enhanced production of glutathione peroxidase, which helps detoxify the liver. Life Code uses a proprietary Schisandra berry extract.

8) Fo-Ti Root (aka He-Shou-Wu) is one of the most widely used Chinese herbal medicines to restore blood, kidney, liver, and cardiovascular health. Fo-Ti is claimed to have powerful rejuvenating effects on the brain, endocrine glands, the immune system, and sexual vigor.

Legend has it that Professor Li Chung Yun took daily doses of Fo-Ti to live to be 256 and is said to have outlived 23 wives and spawned 11 generations of descendents before his death in 1933. While it is unlikely that he really lived to such an old age there is scientific support for Fo-Ti as beneficial for health and longevity.

Like the Indian Keno bark, Fo-ti contains resveratrol analogs and likely acts by various mechanism, which includes liver detoxification and protection of skin from UVB radiation. Life Code uses a proprietary Fo-Ti root extract.

9) Camellia sinensis has many bioactive polyphenols including the potent epigallocatechin-3-gallate (EGCG). A 2006 Japanese study published in the Journal of the American Medical Association reports that adults aged 40 to 79 years of age who drank an average of 5 or more cups of tea per day had a significantly lower risk of dying from all causes (23% lower for females and 12% lower for males). The study tracked more than 40,000 adults for up to 11 years and found dramatically lower rates of cardiovascular disease and strokes in those drinking 5 or more cups of tea.

Many studies have found that adults drinking 3 or more cups of tea per day have significantly less cancer. Other studies have found that green tea helps protect against age-related cognitive decline, kidney disease, periodontal disease, and type 2 diabetes. Green tea also promotes visceral fat loss and higher endurance levels.

Summarizing all of the thousands of studies on tea and tea polyphenols that have been published, it can be concluded that tea polyphenols preserve health and youth. This conclusion is backed up by gene studies showing that tea polyphenols decrease insulin-like growth factor-1 (IGF-1), which is a highly conserved genetic pathway that has been strongly linked to aging in yeast, worms, mice, and humans. If everyone could drink 4 to 5 cups of green tea each day, they could enjoy these important health benefits, but for most people drinking that much green tea can disturb their sleep patterns.

Life Code uses a nutraceutical grade green tea extract that has 98% polyphenols and 50% ESCG that provides the polyphenol and ESCG equivalent of 4 to 5 cups of green tea with only 2% of the caffeine. Thus, most or all of the benefits of green tea are provided without concerns about disturbing sleep.

10) Drynaria Rhizome is used extensively in traditional Chinese medicine as an effective herb for healing bones, ligaments, tendons, and lower back problems. Eastern martial art practitioners have used Drynaria for thousands of years to help in recovering from sprains, bruises, and stress fractures.

Drynaria has also helped in many cases of bleeding gums and tinnitus (ringing in the ears). The active components of Drynaria protect bone forming cells by enhancing calcium absorption and other mechanisms. Drynaria is also reported to act as a kidney tonic and to promote hair growth and wound healing. Life Code uses a proprietary Drynaria rhizome extract.

Safety: The extracts in both versions of Stem Cell 100 are pharmaceutical grade and have been individually tested in both animals and humans without significant safety issues. Those with pre-existing conditions of diabetes or hypertension should coordinate this product with your doctor, as lower blood glucose or reduced blood pressure can result from taking the recommended dose of this product.

Warnings: may lower glucose and/or blood pressure in some individuals. The supplement is not recommended for pregnant, lactating, or hypoglycemic individuals.

References

1. Yu, Q., Y.S. Bai, and J. Lin, [Effect of astragalus injection combined with mesenchymal stem cells transplantation for repairing the Spinal cord injury in rats]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2010. 30(4): p. 393-7.

2. Xu, C.J., et al., [Effect of astragalus polysaccharides on the proliferation and ultrastructure of dog bone marrow stem cells induced into osteoblasts in vitro]. Hua Xi Kou Qiang Yi Xue Za Zhi, 2007. 25(5): p. 432-6.

3. Xu, C.J., et al., [Effects of astragalus polysaccharides-chitosan/polylactic acid scaffolds and bone marrow stem cells on repairing supra-alveolar periodontal defects in dogs]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2006. 31(4): p. 512-7.

4. Zhu, X. and B. Zhu, [Effect of Astragalus membranaceus injection on megakaryocyte hematopoiesis in anemic mice]. Hua Xi Yi Ke Da Xue Xue Bao, 2001. 32(4): p. 590-2.

5. Qiu, L.H., X.J. Xie, and B.Q. Zhang, Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation. Biol Pharm Bull, 2010. 33(4): p. 641-6.

6. Araghi-Niknam, M., et al., Pine bark extract reduces platelet aggregation. Integr Med, 2000. 2(2): p. 73-77.

7. Rohdewald, P., A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther, 2002. 40(4): p. 158-68.

8. Koch, R., Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency. Phytother Res, 2002. 16 Suppl 1: p. S1-5.

9. Rimando, A.M., et al., Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem, 2005. 53(9): p. 3403-7.

10. Manickam, M., et al., Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod, 1997. 60(6): p. 609-10.

11. Grover, J.K., V. Vats, and S.S. Yadav, Pterocarpus marsupium extract (Vijayasar) prevented the alteration in metabolic patterns induced in the normal rat by feeding an adequate diet containing fructose as sole carbohydrate. Diabetes Obes Metab, 2005. 7(4): p. 414-20.

12. Mao, X.Q., et al., Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model. Acta Pharmacol Sin, 2007. 28(12): p. 1947-56.

13. Schafer, A. and P. Hogger, Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase. Diabetes Res Clin Pract, 2007. 77(1): p. 41-6.

14. Kwak, C.J., et al., Antihypertensive effect of French maritime pine bark extract (Flavangenol): possible involvement of endothelial nitric oxide-dependent vasorelaxation. J Hypertens, 2009. 27(1): p. 92-101.

15. Xue, B., et al., Effect of total flavonoid fraction of Astragalus complanatus R.Brown on angiotensin II-induced portal-vein contraction in hypertensive rats. Phytomedicine, 2008.

16. Mizuno, C.S., et al., Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARalpha. Bioorg Med Chem, 2008. 16(7): p. 3800-8.

17. Sato, M., et al., Dietary pine bark extract reduces atherosclerotic lesion development in male ApoE-deficient mice by lowering the serum cholesterol level. Biosci Biotechnol Biochem, 2009. 73(6): p. 1314-7.

18. Kimura, Y. and M. Sumiyoshi, French Maritime Pine Bark (Pinus maritima Lam.) Extract (Flavangenol) Prevents Chronic UVB Radiation-induced Skin Damage and Carcinogenesis in Melanin-possessing Hairless Mice. Photochem Photobiol, 2010.

19. Pavlou, P., et al., In-vivo data on the influence of tobacco smoke and UV light on murine skin. Toxicol Ind Health, 2009. 25(4-5): p. 231-9.

20. Ni, Z., Y. Mu, and O. Gulati, Treatment of melasma with Pycnogenol. Phytother Res, 2002. 16(6): p. 567-71.

21. Bito, T., et al., Pine bark extract pycnogenol downregulates IFN-gamma-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radic Biol Med, 2000. 28(2): p. 219-27.

Read the original post:
Stem Cell 100 Longevity Telomere Support Supplement SC100 ...

Posted in Stem Cell Research | Comments Off

International Society for Stem Cell Research

Posted: July 17, 2016 at 6:40 am

02 March, 2016

The ISSCR annual meeting is a cornerstone of the Society. It provides a core forum for dissemination of ground-breaking research in all areas of stem cell science and translation, with participants from academic, industry, ethics and government settings world-wide. One of the Societys objectives is to choose venues for the annual meeting that reflect its international character, as well as allowing the ISSCR to highlight the contributions of the scientific community in the host region.

26 February, 2016

The International Society for Stem Cell Research (ISSCR) is the worlds leading professional organization of stem cell scientists, representing more than 4,000 members in 45 U.S. states and 65 countries around the world. The ISSCR is opposed to recent efforts to inappropriately limit or prohibit biomedical research using fetal tissue. These proposals, if enacted, would obstruct critical biomedical research and inhibit efforts to improve human health. If enacted in the past, such limits would have delayed or prevented the development of therapies that have saved millions of lives.

26 February, 2016

Growing up, former gymnast and current University of Southern California PhD Candidate Kimberley Nicole Babos, BS always wanted to be a medical doctor, not a scientist doctor (an important distinction for a 12 year old). Find out how identifying roadblocks to efficient induced motor neuron production became the unlikely crux of her PhD thesis in this months Member Spotlight.

10 February, 2016

The International Society for Stem Cell Research (ISSCR) is excited to announce the societys 2016 award recipients, who will be formally recognized at its annual meeting, taking place 22-25 June, 2016 in San Francisco, California, U.S.

Read more from the original source:
International Society for Stem Cell Research

Posted in Stem Cell Research | Comments Off

Vatican Hosts Stem Cell Research Conference Video – ABC News

Posted: July 17, 2016 at 6:40 am

Transcript for Vatican Hosts Stem Cell Research Conference

where robin is there at the Vatican moderating and participating in a conference about the stem cell research that could potentially save lives. Hey, robin, tell us about this conference you're at right now. Well, bon Joran Giorno, Michael. I knew you couldn't resist. Talking about stem cell research and I'm so honored to be asked to share my story and with my sister sally-ann, my big sister sally-ann, many are aware she was my bone marrow donor back in 2012, she is here along with one of my doctors from memorial sloan-kettering back in new York, Dr. Sergio giralt and sharing everything we have gone through in this journey and people are very excited. Hello. Vice president Joe Biden will be addressing this conference tomorrow. You know about his moon shot initiative and of course we're also going to have an audience with the pope but it's really been remarkable, the strides that are being made and the real advances we are seeing in these medical advancements. Robin, all that commotion behind you. I know. That was a remarkable shot. After you've been through what I've been through, what is a little chaos. And we all do remember you were at the Vatican just two weeks before your stem cell transplant. Must be so moving to be back. Oh, many of you there, George, Lara, Amy, Michael, you guys remember, you remember so incredibly well and it was just weeks before I was going to have the transplant and I came here to the Vatican and said a prayer I would be able to have the strength to face whatever it is, whatever the outcome was going to be and this whole conference, guys, which really is very interesting, it's that balance between science and faith. How science interfaces with faith and vice versa and I have to say, you know, when I said to you all I'm going to the Vatican and we're talking about stem cell research and advances and you're like, the Vatican and stem cells? Amazing. Pope Francis, yeah, pope Francis and you know we talk about immunotherapy. Lara, you have a friend going through that. Yep. And so these are the types of advances that we are seeing that are making a true difference and I can't wait to share more with you throughout the morning. Sounds fascinating. We can't wait either. Thank you. Knew we have to go to ginger

This transcript has been automatically generated and may not be 100% accurate.

View post:
Vatican Hosts Stem Cell Research Conference Video - ABC News

Posted in Stem Cell Research | Comments Off

Future of Stem Cell Research – Creating New organs and …

Posted: October 23, 2015 at 5:43 am

Written by Patrick Dixon

Futurist Keynote Speaker: Posts, Slides, Videos - Biotechnology, Genetics, Gene Therapy, Stem Cells

Stem cell research. Embryonic stem cells and adult stem cells - biotech company progress, stem cell investment, stem cell research results, should you invest in stem cell technology, stem cell organ repair and organ regeneration? Treatment using adult stem cells for people like the late Christopher Reeves, with recent spinal cord injuries - or stroke, or heart damage.

Comment by Dr Patrick Dixon on stem cell research and science of ageing, health care, life expectancy, medical advances, pensions, retirement, lifestyles. (ReadFREE SAMPLE of The Truth about Almost Everything- his latest book.)

Every week there are new claims being made about embryonic stem cells and adult stem cells, what is the truth? Scientific facts have often been lost in the media debate. The death of Superman hero Christopher Reeves has also focussed attention on stem cell research, and the urgent needs of those with spinal cord injury.

Here is a brief summary of important stem cell trends. You will also find on this site keynote presentations on stem cell research, speeches and powerpoint slides on the future of health care, the future of medicine, the future of the pharmaceutical industry, and the future of ageing - all of which are profoundly impacted by stem cell research.

There is no doubt that we are on the edge of a major stem cell breakthrough. Stem cells will one day provide effective low-cost treatment for diabetes, some forms of blindness, heart attack, stroke, spinal cord damage and many other health problems. Animal stem cell studies are already very promising and some clinical trials using stem cells have started (article written in September 2004).

As a physician and a futurist I have been monitoring the future of stem cells for over two decades and advise corporations on these issues. Stem cell investment, research effort, and treatment focus is moving rapidly away from embryonic stem cells (ethical and technical challenges) to adult stem cells which are turning out to be far easier to convert into different tissues than we thought.

I have met a number of leading researchers, and their progress in stem cell research is now astonishing, while over 2,000 new research papers on embryonic or adult stem cells are published in reputable scientific journals every year.

Stem cell technology is developing so fast that many stem cell scientists are unaware of important progress by others in their own or closely related fields. They are unable to keep up. The most interesting work is often unpublished, or waiting to be published. There is also of course commercial and reputational rivalry, which can on occasions tempt scientists to downplay the significance of other people's results (or their claims).What exactly are stem cells? Will stem cells deliver? Should you invest in biotech companies that are developing stem cell technology? What should physicians, health care professionals, planners and health departments expect? What will be the impact of stem cell treatments on the pharmaceutical industry? How expensive will stem cell treatments be? What about the ban on embryonic stem cell research in many nations? Do embryonic stem cell treatments have a future or will they be overtaken by adult stem cell technology?

Embryonic stem cells are also hard to control, and hard to grow in a reliable way. They have "minds" of their own, and embryonic stem cells are often unstable, producing unexpected results as they divide, or even cancerous growths. Human embryonic stem cells usually cause an immune reaction when transplanted into people, which means cells used in treatment may be rapidly destroyed unless they are protected, perhaps by giving medication to suppress the immune system (which carries risks).

One reason for intense interest in human cloning technology is so-called therapeutic cloning. This involves combining an adult human cell with a human egg from which the nucleus has been removed. The result is a human embryo which is dividing rapidly to try and become an identical twin of the cloned adult. If implanted in the womb, such cloned embryos have the potential to be born normally as cloned babies, although there are many problems to overcome, including catastrophic malformations and premature ageing as seen in animals such as Dolly the sheep.

In theory, therapeutic cloning could allow scientists to take embryonic stem cells from the cloned embryo, throw the rest of the embryo away and use the stem cells to generate new tissue which is genetically identical to the person cloned. In practice, this is a very expensive approach fraught with technical challenges as well as ethical questions and legal challenges.

An alternative is to try to create a vast tissue bank of tens of thousands of embryonic cells lines, by extracting stem cells from so many different human embryos that whoever needs treatment can be closely matched with the tissue type of an existing cell line. But even if this is achieved, problems of control and cancer remain. And again there are many ethical considerations with any science that uses human embryos, each of which is an early developing but complete potential human being, which is why so many countries have banned this work.

However a moment's thought tells us how illogical such a view was, and indeed we are now finding that many cells in children and adults have extraordinary capacity to generate or stimulate growth of a wide variety of tissues, if encouraged in the right way.

Take for example the work of Professor Jonathan Slack at Bath University who has shown how adult human liver cells can be transformed relatively easily into insulin producing cells such as those found in the pancreas, or the work of others using bone marrow cells to repair brain and spinal cord injuries in mice and rats, and now doing the same to repair heart muscle in humans.

Why should this surprise us? We know that almost all cells in your body contain your entire genome or book of life: enough information to make an entire copy of you, which is the basis of cloning technology. So in theory, just about every cell can make any tissue you need. However, the reality is that in most cells almost every gene you have is turned off - but as it turns out, not as permanently as we thought.

If we take one of your skin cells and fuse it with an unfertilized human egg, the chemical bath inside a human egg activates all the silenced genes, and the combined cell becomes so totipotent that it starts to make a new human being.

What then if we could find a way to reactivate just a few silenced genes, and perhaps at the same time silence some of the others? Could we find a chemical that would mimic what happens in the embryo, with the power to transform cells from one type into another? Yes we can. Jonathan Slack and others have done just that. What was considered impossible five years ago is already history.

Could we take adult cells and force them back into a more general, undetermined embryonic state? Yes we can. It is now possible to create cells with a wide range of plasticity, all from adult tissue. The secret is to get the right gene activators into the nucleus, not so hard as we thought.

Suppose you have a heart attack. A cardiothoracic surgeon talks to you about using your own stem cells in an experimental treatment. You agree. A sample of bone marrow is taken from your hips, and processed using standard equipment found in most oncology centers for treating leukemia. The result is a concentrated number of special bone marrow cells, which are then injected back into your own body - either into a vein in your arm, or perhaps direct into the heart itself.

The surgeon is returning your own unaltered stem cells back to you, to whom these cells legally belong. This is not a new molecule requiring years of animal and clinical tests. Your own adult stem cells are available right now. No factory is involved - nor any pharmaceutical company sales team.

What is more, there are no ethical questions (unlike embryonic stem cells), no risk of tissue rejection, no risk of cancer.

Now we begin to see why research funds are moving so fast from embryonic stem cells to adult alternatives.

Harvard Medical School is another center of astonishing progress in adult stem cells. Trials have shown partially restored sight in animals with retinal damage. Clinical trials are expected within five years, using adult stem cells as a treatment to cure blindness caused by macular degeneration - old-age blindness and the commonest cause of sight-loss in America. Within 10 years, it is hoped that people will be able to be treated routinely with their own stem cells in a clinic using a two-hour process.

If you want further evidence of this switch in interest from embryonic to adult stem cells, look at the makers of Dolly the sheep. The Rosslyn Institute in Scotland are pioneers in cloning technology. They, along with others, campaigned successfully in UK Parliament for the legal right to use the same technology in human embryos (therapeutic cloning, not with the aim of clones being born). But three years later, they had not even bothered to apply for a human cloning licence.

Why not? Because investors were worried about throwing money at speculative embryo research with massive ethical and reputational risks. Newcastle University made headlines in August 2004 when granted the first licence to clone human embryos - but the real story was why it had taken so long to get a single research institute in the UK to actually get on and apply. Answer: medical research moved on and left the "therapeutic" human cloners behind.

The debate centers on technical questions and semantics, rather than the reality of results. Take for example heart repair. We know that bone marrow cells can land up in damaged heart and when present, the heart is repaired. It is hard to be certain what proportion of this remarkable process is due to stimulants released locally by bone marrow cells, or by the bone marrow cells actually differentiating into heart tissue.

It remains a confusing picture, not least because in the lab, cells seem to change character profoundly, but in clinical trials it appears the effects of many stem cells are stimulatory. But who cares? As a clinician, I am delighted if injecting your bone marrow cells into your back means that you are walking around 3 months after a terrible injury to your spine instead of being in a wheelchair for the rest of your life. I am not so concerned with exactly how it all works, and nor will you be.

In summary, expect rapid progress in adult stem cells and slower, less intense work with embryonic stem cells. Embryonic stem cell technology is already looking rather last-century, along with therapeutic cloning. History will show that, by 2020, we were already able to produce a wide range of tissues using adult stem cells, with spectacular progress in tissue building and repair. In some cases, these stem cells will be actually incorporated into the new repairs as differentiated cells, in other cases, they will be temporary assistants in local repair processes.

And along the way we will see a number of biotech companies fold, as a result of over-investment into embryonic stem cells, plus angst over ethics and image, without watching the radar screen closely enough, failing to see the onward march of adult stem cell technology.

Using embryos as a source of spare-part cells will always be far more controversial than using adult tissue, or perhaps cells from umbilical cord after birth, and investors will wish to reduce uneccessary risk, both to the projects they fund, and to their own organisations by association.

Despite this, we can expect embryonic stem cell research to continue in some countries, with the hope of scientific breakthroughs of various kinds.

Article written May 2004.

Novartis Pumps $15M Into Israeli Stem Cell Research Firm …

Posted: October 20, 2015 at 12:46 am

The Swiss drug maker Novartis will invest an extra $15 million in Gamida Cell, an Israeli developer of stem cell therapies, Gamida said.

Novartis last year invested $35 million in the company for a 15 percent stake, the Tachles Jewish weekly of Switzerland reported this week. The deal could reach $600 million if Novartis exercises a buyout option that expires in 2016.

The $15 million investment will be used to advance Gamida Cells clinical programs, including the development of an experimental treatment for patients with high risk hematological malignancies, or blood cancers such as leukemia and lymphoma and sickle cell disease.

Gamida plans to initiate a Phase III clinical trial with NiCord in mid-2016, according to Reuters.

Novartis will not have rights or options to Gamida Cell products or technology under the terms of the agreement.

Other Gamida shareholders include Israeli firms that have been the subjects of politically motivated divestment by European business, including Elbit Imaging and Teva Pharmaceutical Industries.

See the rest here:
Novartis Pumps $15M Into Israeli Stem Cell Research Firm ...

Posted in Stem Cell Research | Comments Off

Page 38«..10 20..373839 40..50 60..»

Category Archives: Stem Cell Research

Stem Cell Research News Topix

Cell and Stem Cell Conferences | Exhibitions | Worldwide …

Texans for Stem Cell Research

Does Texas Have Research Now? | Texans for Stem Cell Research

Embryonic stem cell research: an ethical dilemma | Europe’s …

Stem Cell 100 Longevity Telomere Support Supplement SC100 …

International Society for Stem Cell Research

Vatican Hosts Stem Cell Research Conference Video – ABC News

Future of Stem Cell Research – Creating New organs and …

Novartis Pumps $15M Into Israeli Stem Cell Research Firm …

Categories

Archives

Recommended Sites

Contact Us

Recent Posts